Evabosmig
Evabosmig (AGA2118) is a bispecific antibody targeting SOST/sclerostin and DKK-1. Evabosmig binds to both SOST and DKK-1 simultaneously, activates the Wnt/β-catenin signaling pathway, and thereby potently promotes osteogenesis. Evabosmig can be used for the study of osteoporosis.
For research use only. We do not sell to patients.
- CAS No.: 3061142-96-6
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
immunoglobulin (H-gamma4_L-kappa) (H-gamma4_L-kappa)
Human
SOST/Sclerostin & DKK1
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
IgG4-kappa
ELISA, FACS, Functional assay
Chemical Information
-
CAS No. 3061142-96-6
-
SMILES
[Evabosmig]
-
Synonyms
AGA2118
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)